EPO and anemia (phenotype): Anaemia is a frequent clinical manifestation in the cancer patient, and may be caused by the tumour burden itself, chemotherapy drugs such as cisplatin, blood loss or diminished response to Epo (Skillings et al, 1993; Erslev, 2000).